Therapy for lower-risk MDS

Lower-risk myelodysplastic syndromes (MDS) are characterized by the presence of dysplasia, low bone marrow blast percentage, low number and depth of cytopenia(s), and relatively good-risk karyotpic and molecular abnormalities. A score of ≤3.5 on the Revised International Prognostic Scoring System cl...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Hematology Am Soc Hematol Educ Program
Asıl Yazarlar: Carraway, Hetty E., Saygin, Caner
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: American Society of Hematology 2020
Konular:
Myelodysplastic Syndromes: What We Have and What We Want
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7727572/
https://ncbi.nlm.nih.gov/pubmed/33275714
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/hematology.2020000127
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller